Stock Analysis on Net

Walgreens Boots Alliance Inc. (NASDAQ:WBA)

$22.49

This company has been moved to the archive! The financial data has not been updated since July 9, 2020.

Analysis of Revenues

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Revenues as Reported

Walgreens Boots Alliance Inc., income statement, revenues

US$ in millions

Microsoft Excel
12 months ended: Aug 31, 2019 Aug 31, 2018 Aug 31, 2017 Aug 31, 2016 Aug 31, 2015 Aug 31, 2014
Pharmacy
Retail
Retail Pharmacy USA
Pharmacy
Retail
Retail Pharmacy International
Pharmaceutical Wholesale
Eliminations
Sales

Based on: 10-K (reporting date: 2019-08-31), 10-K (reporting date: 2018-08-31), 10-K (reporting date: 2017-08-31), 10-K (reporting date: 2016-08-31), 10-K (reporting date: 2015-08-31), 10-K (reporting date: 2014-08-31).


Overall Revenue Trend
The total sales revenue exhibited a consistent upward trend over the three-year period from 2017 to 2019. Sales increased from $118,214 million in 2017 to $136,866 million in 2019, indicating a growth momentum in the company's overall business operations.
Retail Pharmacy USA
The Retail Pharmacy USA segment showed strong growth each year between 2017 and 2019. Revenue increased from $87,302 million in 2017 to $104,532 million in 2019, reflecting steady expansion and possibly increased market share within the United States. This segment constitutes the largest share of revenue within the retail pharmacy operations.
Pharmacy and Retail Segments
The Pharmacy segment experienced significant revenue growth from 2017 ($60,607 million) to 2019 ($77,192 million). The Retail segment revenues remained relatively stable, with a slight increase from 2017 ($26,695 million) to 2018 ($27,337 million) followed by a plateau at $27,340 million in 2019. This suggests the pharmacy services contributed more heavily to revenue growth compared to retail sales.
Retail Pharmacy International
Revenues from the Retail Pharmacy International segment show slight fluctuation with a modest decline from $12,281 million in 2018 to $11,462 million in 2019. This indicates some challenges or market contractions internationally during the last reported year.
Pharmaceutical Wholesale
The Pharmaceutical Wholesale division revenue increased from $21,188 million in 2017 to $23,053 million in 2019. This steady increase signals an expanding wholesale business that is contributing positively to the company’s revenue base.
Pharmacy within Retail Pharmacy International
Pharmacy-specific revenue within the Retail Pharmacy International segment declined in 2019 to $4,080 million from $4,360 million in 2018, potentially reflecting competitive pressures or reduced demand in these markets.
Retail within Retail Pharmacy International
Retail revenue within the international segment decreased from $7,921 million in 2018 to $7,382 million in 2019, further emphasizing the overall downturn in international retail pharmacy sales.
Eliminations
The data shows consistent eliminations in inter-segment transactions, increasing marginally from -$2,089 million in 2017 to -$2,181 million in 2019. This reflects internal offsets to consolidated revenue, maintaining a stable proportion relative to total sales.